AMRX - Amneal Pharmaceuticals, Inc.

13.02
-0.240   -1.843%

Share volume: 1,048,886
Last Updated: 04-21-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.15%

PREVIOUS CLOSE
CHG
CHG%
$13.26
-0.24
-0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
59%
Profitability 58%
Dept financing 43%
Liquidity 68%
Performance 61%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-6.40%
1 Month
9.23%
3 Months
9.23%
6 Months
9.23%
1 Year
9.23%
2 Year
9.23%
Key data
Stock price
$13.02
P/E Ratio 
N/A
DAY RANGE
$12.96 - $13.36
EPS 
$0.11
52 WEEK RANGE
$11.71 - $13.92
52 WEEK CHANGE
$9.23
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
314.629 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$1,393,396
AVERAGE 30 VOLUME 
$1,523,655
Company detail
CEO: Chintu Patel
Region: US
Website: amneal.com
Employees: 7,600
IPO year: 2018
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Amneal Pharmaceuticals, Inc. develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products. The company operates through three segments: Generics, Specialty, and AvKARE. It sells its products through wholesalers, distributors, hospitals, chain pharmacies, and individual pharmacies.

Recent news